Leena Palomo

Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors.

BACKGROUND Rheumatoid arthritis (RA) and periodontitis are common chronic inflammatory conditions. Recent studies showed a beneficial effect of periodontal treatment on the severity of active RA. This study was undertaken to further examine the effect of non-surgical periodontal treatment on the signs and symptoms of RA in patients treated with or without anti-tumor necrosis factor-alpha (anti-TNF-alpha) medications. The effect of anti-TNF-alpha therapy on periodontitis also was assessed. METHODS Forty participants diagnosed with moderate/severe RA (under treatment for RA) and severe periodontitis were randomly assigned to receive initial non-surgical periodontal therapy with scaling/root planing and oral hygiene instructions (n = 20) or no periodontal therapy (n = 20). To control RA, all participants had been using disease-modifying anti-rheumatic drugs, and 20 had also been using anti-TNF-alpha before randomization. Probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI), plaque index (PI), RA disease activity score 28 (DAS28), and erythrocyte sedimentation rate (ESR) were measured at baseline and 6 weeks later. Linear mixed models were used to identify significant differences between subjects who received periodontal treatment and those who did not. RESULTS Patients receiving periodontal treatment showed a significant decrease in the mean DAS28, ESR (P <0.001), and serum TNF-alpha (P <0.05). There was no statistically significant decrease in these parameters in patients not receiving periodontal treatment. Anti-TNF-alpha therapy resulted in a significant improvement in CAL, PD, BOP, and GI. CONCLUSIONS Non-surgical periodontal therapy had a beneficial effect on the signs and symptoms of RA, regardless of the medications used to treat this condition. Anti-TNF-alpha therapy without periodontal treatment had no significant effect on the periodontal condition.

Reliability and accuracy of cone-beam computed tomography dental measurements

INTRODUCTION Dental measurements are an integral part of the orthodontic records necessary for proper diagnosis and treatment planning. In this study, we investigated the reliability and accuracy of dental measurements made on cone-beam computed tomography (CBCT) reconstructions. METHODS Thirty human skulls were scanned with dental CBCT, and 3-dimensional reconstructions of the dentitions were generated. Ten measurements (overbite, overjet, maxillary and mandibular intermolar and intercanine widths, arch length available, and arch length required) were made directly on the dentitions of the skulls with a high-precision digital caliper and on the digital reconstructions with commercially available software. Reliability and accuracy were assessed by using intraclass correlation and paired Student t tests. A P value of < or = 0.05 was used to assign statistical significance. RESULTS Both the CBCT and the caliper measurements were highly reliable (r >0.90). The CBCT measurements tended to slightly underestimate the anatomic truth. This was statistically significant only for compounded measurements. CONCLUSIONS Dental measurements from CBCT volumes can be used for quantitative analysis. With the CBCT images, we found a small systematic error, which became statistically significant only when combining several measurements. An adjustment for this error allows for improved accuracy.

Accuracy and reliability of cone-beam computed tomography for measuring alveolar bone height and detecting bony dehiscences and fenestrations

INTRODUCTION The purpose of this study was to evaluate the accuracy and reliability of cone-beam computed tomography (CBCT) in the diagnosis of naturally occurring fenestrations and bony dehiscences. In addition, we evaluated the accuracy and reliability of CBCT for measuring alveolar bone margins. METHODS Thirteen dry human skulls with 334 teeth were scanned with CBCT technology. Measurements were made on each tooth in the volume-rendering mode from the cusp or incisal tip to the cementoenamel junction and from the cusp or incisal tip to the bone margin along the long axis of the tooth. The accuracy of the CBCT measurements was determined by comparing the means, mean differences, absolute mean differences, and Pearson correlation coefficients with those of direct measurements. Accuracy for detection of defects was determined by using sensitivity and specificity. Positive and negative predictive values were also calculated. RESULTS The CBCT measurements showed mean deviations of 0.1 +/- 0.5 mm for measurements to the cementoenamel junction and 0.2 +/- 1.0 mm to the bone margin. The absolute values of the mean differences were 0.4 +/- 0.3 mm for the cementoenamel junction and 0.6 +/- 0.8 mm for the bone margin. The sensitivity and specificity of CBCT for fenestrations were both about 0.80, whereas the specificity for dehiscences was higher (0.95) and the sensitivity lower (0.40). The negative predictive values were high (>or=0.95), and the positive predictive values were low (dehiscence, 0.50; fenestration, 0.25). The reliability of all measurements was high (r >or=0.94). CONCLUSIONS By using a voxel size of 0.38 mm at 2 mA, CBCT alveolar bone height can be measured to an accuracy of about 0.6 mm, and root fenestrations can be identified with greater accuracy than dehiscences.

How menopause affects oral health, and what we can do about it

After menopause, women become more susceptible to periodontal disease. We believe the problem is due in large part to estrogen deficiency with resulting bone loss and inflammatory processes. Osteoporosis and periodontal disease are best diagnosed early so that treatment can be started sooner and fractures and tooth loss can be prevented. After menopause, women become more susceptible to periodontal disease. The problem may stem in large part from estrogen deficiency.

Response to Periodontal Therapy in Patients Who Had Weight Loss After Bariatric Surgery and Obese Counterparts: A Pilot Study

BACKGROUND Periodontitis and obesity are both chronic health problems, and the literature supports an association between the two. Weight loss after bariatric surgery (BS) has been shown to decrease overall mortality as well as the development of new health-related conditions in morbidly obese patients. The present study aims to assess whether significant weight loss would improve the response to non-surgical periodontal therapy in obese patients. METHODS This study included 30 obese (body mass index >30 kg/m(2)) patients affected with chronic periodontitis. Of these, 15 patients had previously undergone BS and lost ≥40% of their excess weight for ≥6 months after surgery. The other 15 patients were also obese but did not have the surgery, nor did they lose weight to serve as a control group. All participants received non-surgical periodontal therapy (scaling and root planing and oral hygiene instructions). Probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI), and plaque index were measured at baseline and at 4 to 6 weeks after the periodontal treatment. Descriptive statistics, linear mixed-effects models, and linear regression models were used for data analysis. RESULTS The mean age of the study participants was 47.1 ± 11.5 years, and 36.7% of the participants were males. There was a statistically significant improvement after periodontal therapy in the BS compared with the obese group (P <0.05). The PD had a mean reduction of 0.45 mm in the BS group versus 0.28 mm in the control group. The reduction in CAL was 0.44 mm versus 0.30 mm, percentage of BOP sites was 16% versus 15%, and GI was 1.03 versus 0.52 in the BS and control groups, respectively. CONCLUSION An improved response to non-surgical periodontal therapy is observed in obese patients who had significant weight loss after BS compared with obese patients who did not have such a surgery.

Cone Beam CT for Diagnosis and Treatment Planning in Trauma Cases

Three-dimensional imaging offers many advantages in making diagnoses and planning treatment. This article focuses on cone beam CT (CBCT) for making diagnoses and planning treatment in trauma-related cases. CBCT equipment is smaller and less expensive than traditional medical CT equipment and is tailored to address challenges specific to the dentoalveolar environment. Like medical CT, CBCT offers a three-dimensional view that conventional two-dimensional dental radiography fails to provide. CBCT combines the strengths of medical CT with those of conventional dental radiography to accommodate unique diagnostic and treatment-planning applications that have particular utility in dentoalveolar trauma cases. CBCT is useful, for example, in identifying tooth fractures relative to surrounding alveolar bone, in determining alveolar fracture location and morphology, in analyzing ridge-defect height and width, and in imaging temporomandibular joints. Treatment-planning applications include those involving extraction of fractured teeth, placement of implants, exposure of impacted teeth, and analyses of airways.

Periodontal assessment of postmenopausal women receiving risedronate.

Objective:The purpose of this study was to compare periodontal status of postmenopausal women with mild to moderate osteoporosis who use risedronate therapy with those who do not. Design:In this cross-sectional study, a total of 60 age-matched postmenopausal women with mild to moderate osteoporosis diagnosed by a bone density scan T score below −2.5 at either spine or hip were divided into two groups. Women in the experimental group had used systemic risedronate once weekly (35 mg) for at least 3 months. Women in the control group had never used bisphosphonate therapy. The periodontal status of each subject was evaluated through a clinical periodontal examination including evaluation of periodontal probing depth, gingival recession, gingival index, plaque score, attachment loss, and alveolar bone level. The significance in differences between the two groups was assessed using two-tailed paired t tests. Results:Significant differences (P < 0.05) were found between risedronate and control groups for periodontal probing depth (2.6 vs 2.9 mm), gingival index (0.37 vs 0.71), plaque score (56.2 vs 77.0), attachment loss (2.8 vs 3.2 mm), and alveolar bone level (3.1 and 4.0), respectively. Gingival recession parameters did not differ significantly. Five of six periodontal parameters evaluated show that postmenopausal women with mild to moderate osteoporosis using risedronate therapy have healthier periodontal status than those who do not use bisphosphonates. Conclusions:Women using risedronate therapy show significantly less plaque accumulation, less gingival inflammation, lower probing depths, less periodontal attachment loss, and greater alveolar bone levels. These observations suggest that risedronate therapy may play a beneficial role in periodontal status.

Bisphosphonates and osteonecrosis of the jaw: innocent association or significant risk?

Published case series and systematic reviews have documented an association between bisphosphonates and osteonecrosis of the jaw. However, a cause-and- effect relationship has not been established, and most of the reported cases have been in patients with cancer who were receiving much higher doses than those used to treat osteoporosis or Paget disease of bone. The risk, if any, to patients with these latter conditions receiving these drugs appears to be very small. A cause-and-effect relationship has not been established, and most of the reported cases have been in patients with cancer who were receiving much higher doses than those used in osteoporosis or Paget disease of the bone.

Is long-term bisphosphonate therapy associated with benefits to the periodontium in postmenopausal women?

Objective: The aim of this study was to compare the periodontium of postmenopausal women with known low bone mineral density who are receiving long-term bisphosphonate therapy with those who are not. Methods: The periodontal status of 28 white postmenopausal women with low bone density using bisphosphonate therapy for at least 2 years was compared with that of a matching group not using such therapy. All women underwent a cone-beam CT scan of the jaw and a complete periodontal examination evaluating for plaque score, periodontal probing depth, clinical attachment loss, bleeding on probing, and alveolar bone height. Results: Bisphosphonate users had higher plaque score, lower probing depth, and lesser clinical attachment loss compared with the controls. These differences were determined to be significant by both t test and Wilcoxons tests. Bleeding on probing was lower and the alveolar bone height was higher in the bisphosphonate group than in controls, but these differences were not statistically significant. Linear models showed no significant interactions between plaque score and bisphosphonate use, suggesting that the association of periodontal status and outcome measures was constant across all levels of plaque scores. Bisphosphonate use was a significant factor for probing depth but was not significant for the other parameters when adjusted for plaque score. Conclusions: Long-term bisphosphonate use seems to have some beneficial effects on the periodontium of postmenopausal women with low bone density, across all levels of plaque score.

Skeletal bone diseases impact the periodontium: a review of bisphosphonate therapy

Healthcare professionals should be aware that systemic bone conditions impact the periodontium. Bisphosphonate drugs used for systemic bone loss affect the maxilla and mandible. Alveolar bone loss in periodontitis and skeletal bone loss share common mechanisms. At present, bisphosphonates are in wide use for prevention and treatment of osteoporosis, Paget’s disease and metastatic bone conditions. This therapy is linked to a negative side effect called osteonecrosis of the jaws. At the same time, bisphosphonate therapy is also reported to be beneficial to the periodontium. In fact, periodontal therapy using bisphosphonates to modulate host response to bacterial insult may develop into a potential strategy in populations in which periodontal therapy is not convenient. Unlocking the full potential of bisphosphonates involves understanding the mechanisms of action of different classes of bisphosphonates, limiting unwanted side effects and expanding its indications. Developing bisphosphonates to slow the progression of periodontal disease depends on identifying an effective dosage regimen and delivery system that would reach the target site in the periodontium, while limiting unwanted side effects.